The Effect of Sucralfate Slurry in Patients With Eosinophilic Esophagitis

Overview

About this study

Could Sucralfate be a non-steriodal treatment option for patients with Eosinophilic esophagitis?

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion criteria:

• Patients between the ages of 18 and 80 with eosinophilic esophagitis diagnosed by a combination of compatible symptoms, endoscopic findings, histology, and lack of response to proton pump inhibitors.

Exclusion criteria:

Medical conditions such as severe heart or lung disease that preclude safe performance of endoscopy
Pregnant and lactating females will be excluded
Diabetic patients will be excluded as episodes of hyperglycemia have been reported
Patient with chronic renal failure/on dialysis will be excluded
Patients with conditions known to be associated with esophageal eosinophilia, including Crohn's disease, Churg-Strauss, achalasia, and hypereosinophilic syndrome
Inability to read due to: Blindness, cognitive dysfunction, or English language illiteracy

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location	Status
Rochester, Minn. Mayo Clinic principal investigator David Katzka	Closed for enrollment

Mayo Clinic Location

Status

Rochester, Minn.

Mayo Clinic principal investigator

David Katzka

Closed for enrollment

More information

Publications

Publications are currently not available

Clinical Trials